semaglutide off shortage list is on the As of February 21, 2025, the FDA updated its drug is semaglutide coming off the
Description
Oro says
Use of GLP-1 analogue drugs is associated with benefits but also health risks The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and obesity, may be associated with a wide range of health effects, both positive - such as a reduced risk of cardiometabolic disorders - and negative - an increased risk of gastrointestinal conditions or hypertension
And its all thanks to the hypothalamus
PMID: 8462365
